Pathway crosstalk analysis for potential therapeutic intervention identified a network of 53 interconnecting genes (Figure 6D), including genes that are already therapeutic targets in AS and other autoimmune conditions, such as JAK1 and TYK2, alongside yet unexplored genes. This evidence concerns the gene JAK1 and Autoimmunity.